From owner-metabolic-reg@net.bio.net Mon Jul 05 23:57:00 1999
Path: biosci!agate!newsfeed.berkeley.edu!newsfeed.tli.de!bignews.mediaways.net!newsfeed.nettuno.it!server-b.cs.interbusiness.it!news.tin.it!not-for-mail
From: shemoon@tin.it (Claudia Lazzaretto)
Newsgroups: bionet.metabolic-reg
Subject: Sibutramine - looking for informations
Date: Sun, 04 Jul 1999 10:19:04 GMT
Organization: none
Lines: 13
Message-ID: <3784331d.2691263@news.tin.it>
Reply-To: shemoon@tin.it
NNTP-Posting-Host: a-pd22-59.tin.it
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-Newsreader: Forte Agent 1.5/32.452

I'm looking for any information about the new (for me) medicine based
on the active principle called "sibutramine hydrochloride
monohydrate"; up to now I know it is commercialized in the U.S.A. by
Knoll Pharmaceutical Company with the name "MERIDIA".
I would like to know above all if it is or when it'll be available in
Europe or, better, here in ITALY, and then if there are anyone here
around who have already tried it, and obtaining good results or not...
Please, help me if you can: I need another hope 'cause I've already
tried with everything, surgery included when I was 21, and now I'm
really in  serious condition...   You can answer by e-mail if you
prefer (to shemoon@tin.it); I don't know the "policy" of this
newsgroup so well: it is allowed to speak around a specific commercial
product?   Thanks a lot...

.